Drugs commonly taken for a variety of common medical conditions including insomnia, allergies, or incontinence negatively affect the brain causing long term cognitive impairment in older African-Americans, according to a study appearing in the July 13, 2010 print issue of Neurology, the medical journal of the American Academy of Neurology.
Two papers presented at an international obesity conference yesterday have found that a range of the most popular weight loss supplements available on the market are no more effective than a placebo. Neither of the studies, presented at the International Congress on Obesity in Stockholm, Sweden, have yet to be published. According to the author of one of the papers, the science backing a variety of weight loss supplements is lacking.
Postmenopausal women with diabetes taking thiazolidinediones (TZDS), including rosiglitazone and pioglitazone, may be at increased risk for fractures, according to a new study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).
Consumer Reports Health just published an exposé of twelve “dangerous supplements.” It’s an example of such skewed information and biased reporting from a once respected organization that we have issued a new Action Alert.
Drugs commonly taken for a variety of common medical conditions including insomnia, allergies, or incontinence negatively affect the brain causing long-term cognitive impairment in older African-Americans, according to a study appearing in the July 13, 2010 print issue of Neurology, the medical journal of the American Academy of Neurology.
Recalls of prescription and over-the-counter drugs are surging, raising questions about the quality of drug manufacturing in the United States, according to CNN. The Food and Drug Administration reported more than 1,742 recalls last year, skyrocketing from 426 in 2008, according to the Gold Sheet, a trade publication on drug quality that analyzes FDA data.
People who take bisphosphonates, or bone-strengthening drugs for osteoporosis, may have a slightly higher risk of developing esophageal cancer, especially if they take them for several years, a study out this week in the British Journal of Medicine finds.
People who take oral bisphosphonates for bone disease over five years may be doubling their risk of developing oesophageal cancer (cancer of the gullet), according to a new study published online in the British Medical Journal.
A diabetes drug taken by up to 100,000 patients increases the risk of heart attacks and should be withdrawn on safety grounds, senior doctors say today. A report by the British Medical Journal says Avandia should never have been licensed in Britain because its risks outweigh its benefits. One UK expert has calculated that the drug may cause as many as 1,000 extra heart attacks a year in Britain.
The pharmaceutical industry is a "market for lemons," a market in which the seller knows much more than the buyer about the product and can profit from selling products less effective and less safe than consumers are led to believe, according to an analysis that will be presented at the 105th Annual Meeting of the American Sociological Association.
Scientists are calling for more research on the possibility that some supposedly healthful plant-based antioxidants -- including those renowned for their apparent ability to prevent cancer -- may actually aggravate or even cause cancer in some individuals.
Are megabucks of drug company advertising buying major media silence about shoddy practices?
You’ll never guess the name of the company we are about to describe. This year alone it has issued nine product recalls, over 130 million of their products are off the shelves, thirty children have died from taking its medications, its CEO has been the subject of Congressional hearings and investigations, its quality problems are called “systemic” by federal investigators, and a number its foreign executives are being investigated or are in prison for bribery charges.